BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX) announced today that executive management will participate in the 25th Annual Oppenheimer Healthcare Conference being held December 10-11, 2014 at the Crowne Plaza Hotel in New York City. The Company is scheduled to present on Wednesday, December 10 at 10:20am (ET) and will provide a corporate update on the KALBITOR® (ecallantide) business, DX-2930 and the Licensing and Funded Research Portfolio (LFRP).
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
